Trump threatens 100% tariff on pharma products next week for companies not building in USnews2025-09-26T01:17:24+00:00September 26th, 2025|Endpoints News|
Catalent moves into new HQ; Fujifilm opens factory in North Carolinanews2025-09-25T15:10:57+00:00September 25th, 2025|Endpoints News|
Biogen gets ‘unexpected’ CRL for high-dose Spinraza, will submit more technical datanews2025-09-24T11:08:55+00:00September 24th, 2025|Endpoints News|
Gates, Clinton orgs team up with Indian manufacturers to make $40 generic of Gilead’s twice-yearly PrEP drugnews2025-09-24T11:00:26+00:00September 24th, 2025|Endpoints News|
FDA warns J&J vaccine plant in South Korea following 2024 inspectionnews2025-09-23T18:54:28+00:00September 23rd, 2025|Endpoints News|
Lilly sets aside $6.5B for new Texas site to make its obesity pill news2025-09-23T17:00:55+00:00September 23rd, 2025|Endpoints News|
FDA hands Scholar Rock a CRL for spinal muscular atrophy drugnews2025-09-23T11:25:22+00:00September 23rd, 2025|Endpoints News|
Eli Lilly sells New Jersey site to Celltrion for $330Mnews2025-09-23T10:59:40+00:00September 23rd, 2025|Endpoints News|
Logistics real estate company Prologis promises £3.9B in UK life sciences investmentnews2025-09-18T14:51:31+00:00September 18th, 2025|Endpoints News|
Leadership changes at Avid Bio and Charles River; Merck KGaA opens €150M Irish sitenews2025-09-18T13:30:05+00:00September 18th, 2025|Endpoints News|
